Cited by 359HER2/EGFR in Cancer ResearchProtein Kinase Regulation and GTPase SignalingLung Cancer Treatments and Mutations

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface

Open access

Zhang, Xuewu, Pickin, Kerry A., Bose, Ron, Jura, Natalia, Cole, Philip A., Kuriyan, John·2007·Nature

DOI 10.1038/nature05998PMC PMC3561764

Open this paper in CoChat — free account

Abstract

Members of the epidermal growth factor receptor family (EGFR/ERBB1, ERBB2/HER2, ERBB3/HER3 and ERBB4/HER4) are key targets for inhibition in cancer therapy. Critical for activation is the formation of an asymmetric dimer by the intracellular kinase domains, in which the carboxy-terminal lobe (C lobe) of one kinase domain induces an active conformation in the other. The cytoplasmic protein MIG6 (mitogen-induced gene 6; also known as ERRFI1) interacts with and inhibits the kinase domains of EGFR and ERBB2 (refs 3–5). Crystal structures of complexes between the EGFR kinase domain and a fragment of MIG6 show that a ∼25-residue epitope (segment 1) from MIG6 binds to the distal surface of the C lobe of the kinase domain. Biochemical and cell-based analyses confirm that this interaction contributes to EGFR inhibition by blocking the formation of the activating dimer interface. A longer MIG6 peptide that is extended C terminal to segment 1 has increased potency as an inhibitor of the activated EGFR kinase domain, while retaining a critical dependence on segment 1. We show that signalling by EGFR molecules that contain constitutively active kinase domains still requires formation of the asymmetric dimer, underscoring the importance of dimer interface blockage in MIG6-mediated inhibition.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature05998

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
ERBB receptors and cancer: the complexity of targeted inhibitors
Hynes, N. E., & Lane, H. A. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1609 · Cited by 3,379
An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor
Zhang, X., Gureasko, J., Shen, K., Cole, P. A., & Kuriyan, J. (2006) · Cell · doi:10.1016/j.cell.2006.05.013 · Cited by 1,650
Self-citation
Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways
Sordella, R., Bell, D. W., Haber, D. A., & Settleman, J. E. (2004) · Science · doi:10.1126/science.1101637 · Cited by 1,605
Structure of the Epidermal Growth Factor Receptor Kinase Domain Alone and in Complex with a 4-Anilinoquinazoline Inhibitor
Stamos, J. L., Sliwkowski, M. X., & Eigenbrot, C. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207135200 · Cited by 1,594
Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex
Jeffrey, P. D., Russo, A. A., Polyák, K., Gibbs, E., Hurwitz, J., Massagué, J., & Pavletich, N. P. (1995) · Nature · doi:10.1038/376313a0 · Cited by 1,455
A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib)
Wood, E. R., Truesdale, A. T., McDonald, O. B., Yuan, D. Y., Hassell, A. M., Dickerson, S. H., Ellis, B., Pennisi, C., Horne, E., Lackey, K. E., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1168 · Cited by 1,125
Crystallographic analysis of the specific yet versatile recognition of distinct nuclear localization signals by karyopherin α
Conti, E., & Kuriyan, J. (2000) · Structure · doi:10.1016/s0969-2126(00)00107-6 · Cited by 310
Self-citation
Mig6 is a negative regulator of EGF receptor–mediated skin morphogenesis and tumor formation
Ferby, I., Reschke, M., Kudlacek, O., Knyazev, P. G., Panté, G., Amann, K., Sommergruber, W., Kraut, N., Ullrich, A., Fässler, R., et al. (2006) · Nature Medicine · doi:10.1038/nm1401 · Cited by 259
EGFR activation coupled to inhibition of tyrosine phosphatases causes lateral signal propagation
Reynolds, A. R., Tischer, C., Verveer, P. J., Rocks, O., & Bastiaens, P. I. H. (2003) · Nature Cell Biology · doi:10.1038/ncb981 · Cited by 235

Flagged first, then by citations

Show all 22 references

Sorted by citations

Items 101–200 of 359

Loss of MIG-6 results in endometrial progesterone resistance via ERBB2
Yoo, J.-Y., Kim, T. H., Shin, J.-H., Marquardt, R. M., Müller, U., Fazleabas, A. T., Young, S. L., Lessey, B. A., Yoon, H.-G., & Jeong, J.-W. (2022) · Nature Communications · doi:10.1038/s41467-022-28608-x · Cited by 46
The activation mechanism of ACK1 (activated Cdc42-associated tyrosine kinase 1)
Lin, Q., Wang, J., Childress, C., & Yang, W. (2012) · Biochemical Journal · doi:10.1042/bj20111575 · Cited by 45
Mechanisms of ErbB receptor negative regulation and relevance in cancer
Fry, W., Kotelawala, L., Sweeney, C. A., & Carraway, K. L. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.07.022 · Cited by 45
Mitogen-Inducible Gene-6 Is a Multifunctional Adaptor Protein with Tumor Suppressor-Like Activity in Papillary Thyroid Cancer
Lin, C., Du, J., Shen, W. T., Whang, E. E., Donner, D. B., Griff, N., He, F., Moore, F. D., Clark, O. H., & Ruan, D. T. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1800 · Cited by 45
Receptor Tyrosine Kinases: Structure, Functions and Role in Human Disease
Yarden, Y., & Wheeler, D. L. (2014) · Springer eBooks · doi:10.1007/978-1-4939-2053-2 · Cited by 44
Effect of Phosphorylation on EGFR Dimer Stability Probed by Single-Molecule Dynamics and FRET/FLIM
Coban, O., Zanetti-Domingues, L. C., Matthews, D. R., Rolfe, D. J., Weitsman, G. E., Barber, P. R., Barbeau, J., Devauges, V., Kampmeier, F., Winn, M., et al. (2015) · Biophysical Journal · doi:10.1016/j.bpj.2015.01.005 · Cited by 44
Constitutive activated Cdc42-associated kinase (Ack) phosphorylation at arrested endocytic clathrin-coated pits of cells that lack dynamin
Shen, H., Ferguson, S. M., Dephoure, N., Park, R. J.-H., Yang, Y., Volpicelli‐Daley, L. A., Gygi, S. P., Schlessinger, J., & Camilli, P. V. D. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-07-0637 · Cited by 42
Temporal Resolution of Autophosphorylation for Normal and Oncogenic Forms of EGFR and Differential Effects of Gefitinib
Kim, Y., Li, Z., Apetri, M. M., Luo, B., Settleman, J. E., & Anderson, K. S. (2012) · Biochemistry · doi:10.1021/bi300476v · Cited by 42
The Relative Expression of Mig6 and EGFR Is Associated with Resistance to EGFR Kinase Inhibitors
Chang, X., Izumchenko, E., Solis, L. M., Kim, M. S., Chatterjee, A., Ling, S., Monitto, C. L., Harari, P. M., Hidalgo, M. M., Goodman, S. N., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068966 · Cited by 40
PIM kinase isoform specific regulation of MIG6 expression and EGFR signaling in prostate cancer cells
Siu, A., Virtanen, C., & Jongstra, J. (2011) · Oncotarget · doi:10.18632/oncotarget.386 · Cited by 39
Finding the missing links in EGFR
Bessman, N. J., & Lemmon, M. A. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2221 · Cited by 39
Acquired savolitinib resistance in non-small cell lung cancer arises via multiple mechanisms that converge on MET-independent mTOR and MYC activation
Henry, R. E., Barry, E., Castriotta, L., Ladd, B., Markovets, A. A., Beran, G. J., Ren, Y., Zhou, F., Adam, A., Zinda, M. J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10859 · Cited by 39
Structure-Based Network Analysis of Activation Mechanisms in the ErbB Family of Receptor Tyrosine Kinases: The Regulatory Spine Residues Are Global Mediators of Structural Stability and Allosteric Interactions
James, K. A., & Verkhivker, G. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113488 · Cited by 40
Glucocorticoid-Induced Suppression of β-Cell Proliferation Is Mediated by Mig6
Colvin, E. S., Ma, H.-Y., Chen, Y., Hernandez, A. M., & Fueger, P. T. (2013) · Endocrinology · doi:10.1210/en.2012-1923 · Cited by 38
RNA-binding protein SAMD4 regulates skeleton development through translational inhibition of Mig6 expression
Niu, N., Xiang, J., Yang, Q., Wang, L., Wei, Z., Chen, L., Yang, L. C., & Zou, W. (2017) · Cell Discovery · doi:10.1038/celldisc.2016.50 · Cited by 39
Structure-Functional Prediction and Analysis of Cancer Mutation Effects in Protein Kinases
Dixit, A., & Verkhivker, G. M. (2014) · Computational and Mathematical Methods in Medicine · doi:10.1155/2014/653487 · Cited by 37
Thymosin beta 4 up‐regulates miR‐200a expression and induces differentiation and survival of rat brain progenitor cells
Santra, M., Chopp, M., Santra, S., Nallani, A., Vyas, S., Zhang, Z. G., & Morris, D. C. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13394 · Cited by 37
Surfactant protein D inhibits activation of non-small cell lung cancer-associated mutant EGFR and affects clinical outcomes of patients
Umeda, Y., Hasegawa, Y., Otsuka, M., Ariki, S., Takamiya, R., Saito, A., Uehara, Y., Saijo, H., Kuronuma, K., Chiba, H., et al. (2017) · Oncogene · doi:10.1038/onc.2017.253 · Cited by 36
The structure-function relationship of oncogenic LMTK3
Ditsiou, A., Cilibrasi, C., Simigdala, N., Papakyriakou, A., Milton‐Harris, L., Vella, V., Nettleship, J. E., Lo, J. H., Soni, S., Smbatyan, G., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc3099 · Cited by 36
Conformational regulation of the EGFR kinase core by the juxtamembrane and C‐terminal tail: A molecular dynamics study
Mustafa, M., Mirza, A., & Kannan, N. (2010) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22862 · Cited by 36
Pathways driving the endocytosis of mutant and wild-type EGFR in cancer
Hampton, K. K., & Craven, R. J. (2014) · Oncoscience · doi:10.18632/oncoscience.67 · Cited by 35
Altered microRNA Expression Profiles and Regulation of INK4A/CDKN2A Tumor Suppressor Genes in Canine Breast Cancer Models
Kabir, F. M. L., DeInnocentes, P., & Bird, R. C. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25243 · Cited by 35
New insights into the control of neurotrophic growth factor receptor signaling: Implications for nervous system development and repair
Alsina, F. C., Ledda, F., & Paratcha, G. (2012) · Journal of Neurochemistry · doi:10.1111/jnc.12021 · Cited by 35
Regulation of Ack1 localization and activity by the amino-terminal SAM domain
Prieto-Echagüe, V., Gucwa, A. L., Brown, D. A., & Miller, W. T. (2010) · BMC Biochemistry · doi:10.1186/1471-2091-11-42 · Cited by 35
Identification and Characterization of Tyrosine Kinase Nonreceptor 2 Mutations in Leukemia through Integration of Kinase Inhibitor Screening and Genomic Analysis
Maxson, J. E., Abel, M. L., Wang, J., Deng, X., Reckel, S., Luty, S. B., Sun, H., Gorenstein, J., Hughes, S. B., Bottomly, D., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-0817 · Cited by 35
Mitogen‐inducible gene‐6 partly mediates the inhibitory effects of prenatal dexamethasone exposure on endochondral ossification in long bones of fetal rats
Zhang, X., Shangguan, Y., Ma, J., Hu, H., Wang, L., Magdalou, J., Chen, L., & Wang, H. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13506 · Cited by 34
Self-citation
Structural and functional characterization of KEOPS dimerization by Pcc1 and its role in t6A biosynthesis
Wan, L. C. K., Pillon, M. C., Thevakumaran, N., Sun, Y., Chakrabartty, A., Guarné, A., Kurinov, I. V., Durocher, D., & Sicheri, F. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw542 · Cited by 34
ErbB polymorphisms: insights and implications for response to targeted cancer therapeutics
Alaoui‐Jamali, M. A., Morand, G. B., & da Silva, S. D. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00017 · Cited by 34
The role of the NDRG1 in the pathogenesis and treatment of breast cancer
Zhao, X., & Richardson, D. R. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188871 · Cited by 34
The Myc Family and the Metastasis Suppressor NDRG1: Targeting Key Molecular Interactions with Innovative Therapeutics
Deng, Z., & Richardson, D. R. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000795 · Cited by 32
Molecular mechanisms of asymmetric RAF dimer activation
Jambrina, P. G., Bohuszewicz, O., Buchete, N., Kölch, W., & Rosta, E. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140025 · Cited by 33
Profiling of protein–protein interactions via single-molecule techniques predicts the dependence of cancers on growth-factor receptors
Lee, H.-W., Choi, B., Kang, H. N., Kim, H., Min, A., Cha, M., Ryu, J. Y., Park, S., Sohn, J., Shin, K., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0212-3 · Cited by 32
Phosphatidylinositol 4,5-bisphosphate in the Control of Membrane Trafficking
Li, S., Ghosh, C., Xing, Y., & Sun, Y. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.49665 · Cited by 33
Targeting the unactivated conformations of protein kinases for small molecule drug discovery
Alton, G., & Lunney, E. A. (2008) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.3.6.595 · Cited by 33
A Cancer-Associated Mutation in Atypical Protein Kinase Cι Occurs in a Substrate-Specific Recruitment Motif
Linch, M., Sanz-García, M., Soriano, E., Zhang, Y., Riou, P., Rossé, C., Cameron, A., Knowles, P., Purkiss, A., Kjaer, S., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004068 · Cited by 33
Carboxyl-Group Footprinting Maps the Dimerization Interface and Phosphorylation-induced Conformational Changes of a Membrane-associated Tyrosine Kinase
Zhang, H., Shen, W., Rempel, D. L., Monsey, J. D., Vidavsky, I., Gross, M. L., & Bose, R. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.005678 · Cited by 32
Self-citation
Context-specific protection of TGFα null mice from osteoarthritis
Usmani, S. E., Ulici, V., Pest, M. A., Hill, T. L., Welch, I. D., & Beier, F. (2016) · Scientific Reports · doi:10.1038/srep30434 · Cited by 32
The role of small adaptor proteins in the control of oncogenic signaling driven by tyrosine kinases in human cancer
Naudin, C., Chevalier, C., & Roche, S. (2016) · Oncotarget · doi:10.18632/oncotarget.6929 · Cited by 33
EGFR Signaling Is Required for Maintaining Adult Cartilage Homeostasis and Attenuating Osteoarthritis Progression
Wei, Y., Ma, X., Sun, H. X., Gui, T., Li, J., Yao, L., Zhong, L., Yu, W. H., Han, B., Nelson, C. L., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4531 · Cited by 31
Ack1: Activation and Regulation by Allostery
Gajiwala, K. S., Maegley, K. A., Ferre, R. A., He, Y.-A., & Yu, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053994 · Cited by 31
Regulation of EGFR trafficking and cell signaling by Sprouty2 and MIG6 in lung cancer cells
Walsh, A. M., & Lazzara, M. J. (2013) · Journal of Cell Science · doi:10.1242/jcs.123208 · Cited by 31
Inhibition of Receptor Dimerization as a Novel Negative Feedback Mechanism of EGFR Signaling
Kluba, M., Engelborghs, Y., Hofkens, J., & Mizuno, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139971 · Cited by 31
The Epidermal Growth Factor Receptor Forms Location-Dependent Complexes in Resting Cells
Yavas, S., Macháň, R., & Wohland, T. (2016) · Biophysical Journal · doi:10.1016/j.bpj.2016.09.049 · Cited by 30
Inhibition of KHSRP sensitizes colorectal cancer to 5‐fluoruracil through miR‐501‐5p‐mediated ERRFI1 mRNA degradation
Pan, R.-J., Cai, W., Sun, J. P., Yu, C., Li, P., & Zheng, M. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29076 · Cited by 30
Structural Stability and Flexibility Direct the Selection of Activating Mutations in Epidermal Growth Factor Receptor Kinase
Paladino, A., Morra, G., & Colombo, G. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00270 · Cited by 30
An Essential Role of cAMP Response Element Binding Protein in Ginsenoside Rg1-Mediated Inhibition of Na+/Glucose Cotransporter 1 Gene Expression
Wang, C.-W., Su, S.-C., Huang, S., Huang, Y.-C., Chan, F., Kuo, Y.-H., Hung, M., Lin, H.-C., Chang, W.-L., & Chang, T. (2015) · Molecular Pharmacology · doi:10.1124/mol.114.097352 · Cited by 29
Overview of Current Type I/II Kinase Inhibitors
Zhao, Z., & Bourne, P. E. (2020) · Springer eBooks · doi:10.1007/978-3-030-48283-1_2 · Cited by 31
Allosteric regulation of epidermal growth factor (EGF) receptor ligand binding by tyrosine kinase inhibitors
Macdonald-Obermann, J. L., & PIKE, L. J. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004139 · Cited by 28
Gefitinib induces EGFR and α5β1 integrin co-endocytosis in glioblastoma cells
Blandin, A.-F., Silva, E. C. D., Mercier, M.-C., Glushonkov, O., Didier, P., Dedieu, S., Schneider, C., Thevenard-Devy, J., Étienne-Selloum, N., Dontenwill, M., et al. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03686-6 · Cited by 28
RNA binding proteins in senescence: A potential common linker for age-related diseases?
Varesi, A., Campagnoli, L. I. M., Barbieri, A., Rossi, L., Ricevuti, G., Esposito, C., Chirumbolo, S., Marchesi, N., & Pascale, A. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101958 · Cited by 29
Mutation of epidermal growth factor receptor is associated with MIG6 expression
Nagashima, T., Ushikoshi‐Nakayama, R., Suenaga, A., Ide, K., Yumoto, N., Naruo, Y., Takahashi, K., Saeki, Y., Taiji, M., Tanaka, H., et al. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07220.x · Cited by 28
Chk1 phosphorylates the tumour suppressor Mig‐6, regulating the activation of EGF signalling
Liu, N., Matsumoto, M., Kitagawa, K., Kotake, Y., Suzuki, S., Shirasawa, S., Nakayama, K. I., Nakanishi, M., Niida, H., & Kitagawa, M. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.88 · Cited by 28
Tyrosine Phosphorylation of Mig6 Reduces Its Inhibition of the Epidermal Growth Factor Receptor
Wang, Z., Raines, L. L., Hooy, R. M., Roberson, H., Leahy, D. J., & Cole, P. A. (2013) · ACS Chemical Biology · doi:10.1021/cb4005707 · Cited by 28
Self-citation
The Tumor Suppressor MIG6 Controls Mitotic Progression and the G2/M DNA Damage Checkpoint by Stabilizing the WEE1 Kinase
Sasaki, M., Terabayashi, T., Weiss, S. M., & Ferby, I. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.064 · Cited by 28
Gene 33/Mig6/ERRFI1, an Adapter Protein with Complex Functions in Cell Biology and Human Diseases
Xu, D., & Li, C. (2021) · Cells · doi:10.3390/cells10071574 · Cited by 27
Targeting Diverse Signaling Interaction Sites Allows the Rapid Generation of Bivalent Kinase Inhibitors
Hill, Z. B., Perera, B. G. K., Andrews, S., & Maly, D. J. (2011) · ACS Chemical Biology · doi:10.1021/cb200387g · Cited by 28
Biology using engineering tools
Birtwistle, M. R., & Kölch, W. (2011) · Cell Cycle · doi:10.4161/cc.10.13.16245 · Cited by 27
Targeting oncogenic transcriptional corepressor Nac1 POZ domain with conformationally constrained peptides by cyclization and stapling
Wu, T., He, P., Wu, W., Chen, Y., & Lv, F. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.05.024 · Cited by 26
Feedback inhibitors of the epidermal growth factor receptor signaling pathways
Gotoh, N. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.06.019 · Cited by 27
A graph theoretic approach to utilizing protein structure to identify non-random somatic mutations
Ryslik, G., Cheng, Y., Cheung, K.-H., Modis, Y., & Zhao, H. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-86 · Cited by 27
JUN-Mediated Downregulation of EGFR Signaling Is Associated with Resistance to Gefitinib in EGFR-mutant NSCLC Cell Lines
Kani, K., Garri, C., Tiemann, K., Malihi, P. D., Punj, V., Nguyen, A. L., Lee, J. S., Hughes, L. D., Alvarez, R. M., Wood, D. M., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0564 · Cited by 26
Targeting Receptor Tyrosine Kinases in Cancer
Köstler, W. J., & Zielinski, C. C. (2014) · Springer eBooks · doi:10.1007/978-1-4939-2053-2_10 · Cited by 26
Mitogen-Inducible Gene 6 Triggers Apoptosis and Exacerbates ER Stress-Induced β-Cell Death
Chen, Y., Colvin, E. S., Maier, B. F., Mirmira, R. G., & Fueger, P. T. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1174 · Cited by 28
A Cross-Linking-Aided Immunoprecipitation/Mass Spectrometry Workflow Reveals Extensive Intracellular Trafficking in Time-Resolved, Signal-Dependent Epidermal Growth Factor Receptor Proteome
Chen, Y., Leng, M., Gao, Y., Zhan, D., Choi, J. M., Song, L., Li, K., Xia, X., Zhang, C., Liu, M., et al. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00427 · Cited by 25
Regulation of the ErbB network by the MIG6 feedback loop in physiology, tumor suppression and responses to oncogene-targeted therapeutics
Anastasi, S., Lamberti, D., Alemà, S., & Segatto, O. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.10.001 · Cited by 24
Phosphorylation-Dependent Conformations of the Disordered Carboxyl-Terminus Domain in the Epidermal Growth Factor Receptor
Regmi, R., Srinivasan, S., Latham, A. P., Kukshal, V., Cui, W., Zhang, B., Bose, R., & Schlau‐Cohen, G. S. (2020) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.0c02327 · Cited by 23
Self-citation
Activating EGFR Signaling Attenuates Osteoarthritis Development Following Loading Injury in Mice
Gui, T., Wei, Y., Luo, L., Li, J., Zhong, L., Yao, L., Beier, F., Nelson, C. L., Tsourkas, A., Liu, X. S., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4717 · Cited by 23
Gene 33/Mig6 inhibits hexavalent chromium-induced DNA damage and cell transformation in human lung epithelial cells
Park, S., Li, C., Zhao, H. L., Darżynkiewicz, Z., & Xu, D. (2016) · Oncotarget · doi:10.18632/oncotarget.6866 · Cited by 23
Screening and discovery of nitro-benzoxadiazole compounds activating epidermal growth factor receptor (EGFR) in cancer cells
Sakanyan, V. A., Angelini, M., Béchec, M. L., Lecocq, M., Benaiteau, F., Rousseau, B., Gyulkhandanyan, A., Gyulkhandanyan, L., Logé, C., Reiter, É., et al. (2014) · Scientific Reports · doi:10.1038/srep03977 · Cited by 23
GADD45γ: a New Vitamin D-Regulated Gene that Is Antiproliferative in Prostate Cancer Cells
Flores, O., & Burnstein, K. L. (2010) · Endocrinology · doi:10.1210/en.2010-0434 · Cited by 23
Inhibitory effect of a dimerization-arm-mimetic peptide on EGF receptor activation
Mizuguchi, T., Uchimura, H., Kakizawa, T., Kimura, T., Yokoyama, S., Kiso, Y., & Saito, K. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.04.080 · Cited by 23
The role and mechanism of RNA-binding proteins in bone metabolism and osteoporosis
Wu, J., Niu, L., Yang, K., Xu, J., Zhang, D., Ling, J., Xia, P., Wu, Y., Liu, X., Liu, J., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102234 · Cited by 23
Necdin controls EGFR signaling linked to astrocyte differentiation in primary cortical progenitor cells
Fujimoto, I., Hasegawa, K., Fujiwara, K., Yamada, M., & Yoshikawa, K. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.11.016 · Cited by 22
Transphosphorylation of EGFR at Y845 plays an important role in its autophosphorylation and kinase activity
Song, H., Huang, L. H., ZHANG, M., Wang, X., SONG, S., & Yang, L. (2014) · Oncology Reports · doi:10.3892/or.2014.3102 · Cited by 21
Profiling the tyrosine phosphoproteome of different mouse mammary tumour models reveals distinct, model-specific signalling networks and conserved oncogenic pathways
Ali, N., Wu, J., Hochgräfe, F., Chan, H., Nair, R., Ye, S., Zhang, L., Lyons, R. J., Pinese, M., Lee, H. C., et al. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0437-3 · Cited by 24
Phosphorylation of Mig6 negatively regulates the ubiquitination and degradation of EGFR mutants in lung adenocarcinoma cell lines
Gandhi, T. K. B., Lynn, J. L. S., Wee, S., Gunaratne, J., & Hong, W. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.11.006 · Cited by 22
Prenatal di-(2-ethylhexyl) phthalate exposure induced myocardial cytotoxicity via the regulation of the NRG1-dependent ErbB2/ErbB4-PI3K/AKT signaling pathway in fetal mice
Yu, D., Zhu, D., Wang, X., Li, B., Li, J., Lu, P., Ji, Y., & Wang, X. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113771 · Cited by 20
Mig6 haploinsufficiency protects mice against streptozotocin-induced diabetes
Chen, Y., Colvin, E. S., Griffin, K. E., Maier, B. F., & Fueger, P. T. (2014) · Diabetologia · doi:10.1007/s00125-014-3311-z · Cited by 20
Understanding the molecular basis of EGFR kinase domain/MIG-6 peptide recognition complex using computational analyses
Moonrin, N., Songtawee, N., Rattanabunyong, S., Chunsrivirot, S., Mokmak, W., Tongsima, S., & Choowongkomon, K. (2015) · BMC Bioinformatics · doi:10.1186/s12859-015-0528-x · Cited by 20
Automatch: Target‐binding protein design and enzyme design by automatic pinpointing potential active sites in available protein scaffolds
Zhang, C., & Lai, L. (2011) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24009 · Cited by 20
Cancer-Type Regulation of MIG-6 Expression by Inhibitors of Methylation and Histone Deacetylation
Zhang, Y., Staal, B., Dykema, K. J., Furge, K. A., & Woude, G. F. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038955 · Cited by 19
Phosphoproteomics-Based Modeling Defines the Regulatory Mechanism Underlying Aberrant EGFR Signaling
Tasaki, S., Nagasaki, M., Kozuka‐Hata, H., Semba, K., Gotoh, N., Hattori, S., Inoue, J., Yamamoto, T. S., Miyano, S., Sugano, S., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013926 · Cited by 19
Structure-based inhibitory peptide design targeting peptide-substrate binding site in EGFR tyrosine kinase
Tavakoli, F., & Ganjalikhany, M. R. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217031 · Cited by 19
In silico screening of epidermal growth factor receptor (EGFR) in the tyrosine kinase domain through a medicinal plant compound database
Sawatdichaikul, O., Hannongbua, S., Sangma, C., Wolschann, P., & Choowongkomon, K. (2011) · Journal of Molecular Modeling · doi:10.1007/s00894-011-1135-z · Cited by 18
Identification of Critical Residues within the Conserved and Specificity Patches of Nerve Growth Factor Leading to Survival or Differentiation
Mahapatra, S., Mehta, H., Woo, S. B., & Neet, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.058420 · Cited by 18
Molecular dynamics of the asymmetric dimers of EGFR: Simulations on the active and inactive conformations of the kinase domain
Songtawee, N., Bevan, D. R., & Choowongkomon, K. (2015) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2015.03.002 · Cited by 18
Accelerated and increased joint damage in young mice with global inactivation of mitogen-inducible gene 6 after ligament and meniscus injury
Joiner, D. M., Less, K. D., Wieren, E. V., Zhang, Y., Hess, D. E., & Williams, B. O. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4522 · Cited by 18
Conformationally constrained peptides target the allosteric kinase dimer interface and inhibit EGFR activation
Fulton, M. D., Hanold, L. E., Ruan, Z., Patel, S., Beedle, A. M., Kannan, N., & Kennedy, E. J. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.08.051 · Cited by 18
Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma
Kang, D. H., Jung, S. S., Yeo, M., Lee, D. H., Yoo, G., Cho, S. Y., Oh, I., Kim, J. O., Park, H. S., Chung, C., et al. (2020) · BMC Cancer · doi:10.1186/s12885-020-07057-z · Cited by 18
MIG6 Is MEK Regulated and Affects EGF-Induced Migration in Mutant NRAS Melanoma
Vu, H. L., Rosenbaum, S. R., Capparelli, C., Purwin, T. J., Davies, M. A., Berger, A. C., & Aplin, A. E. (2015) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2015.11.012 · Cited by 17
Whole genome sequencing of glioblastoma multiforme identifies multiple structural variations involved in EGFR activation
Furgason, J. M., Li, W., Milholland, B., Cross, E., Li, Y., McPherson, C. M., Warnick, R. E., Rixe, O., Stambrook, P. J., Vijg, J., et al. (2014) · Mutagenesis · doi:10.1093/mutage/geu026 · Cited by 16
Mig6 not only inhibits EGFR and HER2 but also targets HER3 and HER4 in a differential specificity: Implications for targeted esophageal cancer therapy
Zhong, H., He, J., Yu, J., Li, X., Mei, Y., Hao, L., & Wu, X. (2021) · Biochimie · doi:10.1016/j.biochi.2021.07.002 · Cited by 16
MIG-6 is essential for promoting glucose metabolic reprogramming and tumor growth in triple-negative breast cancer
He, J., Li, C., Lee, H., Shin, D., Chern, Y., Carvalho, B. P. D., & Chan, C. (2021) · EMBO Reports · doi:10.15252/embr.202050781 · Cited by 17
Domain Architecture of the Nonreceptor Tyrosine Kinase Ack1
Kan, Y., Paung, Y., Seeliger, M. A., & Miller, W. T. (2023) · Cells · doi:10.3390/cells12060900 · Cited by 15
MIG6 loss confers resistance to ALK/ROS1 inhibitors in NSCLC through EGFR activation by low-dose EGF
Kondo, N., Utsumi, T., Shimizu, Y., Takemoto, A., Oh‐hara, T., Uchibori, K., Subat-Motoshi, S., Ninomiya, H., Takeuchi, K., Nishio, M., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.173688 · Cited by 15
Design and Optimization of Peptide Ligands to Target Breast Cancer-Positive HER2 by Grafting and Truncation of MIG6 Peptide
Yu, X., Guo, A.-F., Zheng, G., Yang, X., & Shi, P. (2015) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-015-9501-9 · Cited by 15
Co-Conserved Features Associated with cis Regulation of ErbB Tyrosine Kinases
Mirza, A., Mustafa, M., Talevich, E., & Kannan, N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014310 · Cited by 15
Inhibition of Cdc42 is essential for Mig-6 suppression of cell migration induced by EGF
Jiang, X., Niu, M., Chen, D., Chen, J., Cao, Y., Li, X., Ying, H., Bergholz, J. S., Zhang, Y., & Xiao, Z. J. (2016) · Oncotarget · doi:10.18632/oncotarget.10205 · Cited by 16
Structure-Based Stepwise Screening of PPARγ Antagonists as Potential Competitors with NCOA1 Coactivator Peptide for PPARγ CIS Site
Shen, Y., Chi, H., Zhou, J., Luo, L., Tu, Q., Qi, C., & Gao, Z. (2018) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-018-9782-x · Cited by 15
Rational Optimization of Tumor Suppressor‐Derived Peptide Inhibitor Selectivity between Oncogene Tyrosine Kinases ErbB1 and ErbB2
Deng, Y., & Li, J. (2017) · Archiv der Pharmazie · doi:10.1002/ardp.201700181 · Cited by 14

Authors: Zhang, X., Pickin, K. A., Bose, R., Jura, N., Cole, P. A., & Kuriyan, J.
Affiliations: Howard Hughes Medical Institute (US)
Johns Hopkins University (US)
Corresponding author: Kuriyan, John
ORCID: Zhang, Xuewu
Bose, Ron
Jura, Natalia
Cole, Philip A.
Kuriyan, John
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2007-11-29
Volume: 450
Issue: 7170
Pages: 741-744
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature05998
PMC: PMC3561764
OpenAlex: W2046151919
Semantic Scholar: 84bdab56e088c2422419e9cd91b3387be8d1ee60
Cited by: 357
References: 22
Citations by year: 2026: 17 · 2025: 8 · 2024: 6 · 2023: 13 · 2022: 13 · 2021: 13 · 2020: 16 · 2019: 10 · 2018: 15 · 2017: 20 · 2016: 33 · 2015: 31 · 2014: 37 · 2013: 18 · 2012: 20
FWCI: 10.09
Type: journal article
Language: en
Open access: green
europepmc.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: Susan G. Komen for the Cure
Susan G. Komen
National Institutes of Health
National Cancer Institute (R01CA096504)
Topics: Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Treatments and Mutations
Keywords: epidermal growth factor receptor, MIG6, ERBB2, HER2, allosteric inhibition, EGFR signaling, constitutively active kinase, product inhibition
MeSH terms: Animals, Binding Sites, Chlorocebus aethiops, Humans, Models, Biological, Models, Molecular, Phosphorylation, Protein Binding, Protein Structure, Tertiary, Crystallography, X-Ray, Dimerization, COS Cells, Tumor Suppressor Proteins, Adaptor Proteins, Signal Transducing, ErbB Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks